Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant
Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2011.634039
Full Text
Open PDFAbstract
Available in full text
Date
December 5, 2011
Authors
Publisher
Informa UK Limited